Uterine fibroid – new possibilities of nosotropic therapy

Abstract

In this article are given the results of studies SMRP: ulipristal acetate in the treatment of uterine fibroids, ulipristal acetate (Esmya).

Keywords

• uterine myoma (fibroid)
• selective progesterone-receptor modulator (smrp)
• ulipristal acetate